NCT03519607

Brief Summary

The purpose of this study is to determine if the use of a new app, FertiStrong, is associated with decreased levels of anxiety and depression in men who have infertility or whose partner has infertility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2018

Completed
24 days until next milestone

Study Start

First participant enrolled

April 30, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 9, 2018

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2018

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

May 9, 2018

Status Verified

May 1, 2018

Enrollment Period

2 months

First QC Date

April 6, 2018

Last Update Submit

May 7, 2018

Conditions

Keywords

InfertilityDistressCopingMen

Outcome Measures

Primary Outcomes (1)

  • Anxiety and Depression in Men Experiencing Infertility

    Evaluation of pre and post Hospital Anxiety and Depression Scores

    6 months post study completion

Secondary Outcomes (1)

  • Stress Levels in Men Experiencing Infertility

    6 months post study completion

Study Arms (2)

Treatment Group

ACTIVE COMPARATOR

Participants who are in the intervention group will receive the FertiStrong app downloading instructions as soon as they have been randomized. They will have access to this app for a period of 30 days during the intervention phase of the study.

Behavioral: FertiStrong App

Control Group

NO INTERVENTION

Participants in the control group will not have access to the FertiStrong app for the first 30 days. After a period of 30 days, participants will be provided downloading instructions to this app.

Interventions

FertiStrong AppBEHAVIORAL

The FertiStrong mobile app is similar to FertiCalm, which is designed for women with infertility. FertiCalm (www.FertiCalm.com) can be downloaded for free anywhere in the US, for both Apple and Android phones. Each app contains twelve main categories and each main category contains up to five tailored situations. For each situation, there are six options. Three of the options are the same for all situations (humor, self-nurture, relaxation) and three are unique (cognitive solutions, behavioral solutions, social solutions).

Also known as: FertiStrong
Treatment Group

Eligibility Criteria

Age18 Years - 55 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsMales experiencing infertility, or men whose partner is experiencing infertility
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • All men who are receiving care, or whose partner is receiving care, at Fertility Centers of Illinois during the study period.

You may not qualify if:

  • Does not have daily access to a smart phone
  • Does not read or understand English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fertility Centers of Illinois

Chicago, Illinois, 60610, United States

RECRUITING

MeSH Terms

Conditions

InfertilityMultiple Endocrine Neoplasia Type 1

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesMultiple Endocrine NeoplasiaEndocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesEndocrine System Diseases

Study Officials

  • Meike Uhler, MD

    Fertility Centers of Illinois

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Participant assignment will be masked for data analysis
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: Comparison of distress scores between the intervention group and the control group
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2018

First Posted

May 9, 2018

Study Start

April 30, 2018

Primary Completion

June 30, 2018

Study Completion

December 31, 2018

Last Updated

May 9, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations